Lilly and Baxter accused of fixing insulin prices in Mexico
This article was originally published in Scrip
Executive Summary
Mexico's antitrust commission, the Comisi�n Federal de Competencia (CFC), has said that Lilly, Baxter and several local firms colluded to fix the prices of their diabetes drugs. It plans to fine them Ps21.5 million ($1.7 million) each, the maximum penalty, although the firms deny any wrong doing.